Grunsven Jasper Van Receives Stock Award at Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Sep 10, 2026

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
Grunsven Jasper Van
EVP
TXN 2026-09-08 · FILED 2026-09-10
Equity Position 8.68K sh 0 → 8,682
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Vertex Pharmaceuticals Inc MA

VRTX CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Filing Date
2026-09-10
Report Date
2026-09-10
Accession No.
0000875320-26-000272
Accepted At
2026-09-10 20:31 UTC
Reporting Owner
Name Relationship
Grunsven Jasper Van CIK 0002154061
EVP
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-09-08 A - Award/Grant 8,682 A $0.00 — 8,682 Direct
Footnotes (1)
F1
Restricted stock unit award that vests in installments beginning on 09/08/2027. Show more

Related filings at Vertex Pharmaceuticals Inc MA

Institutional Holders
13F holders · Jun 30, 2026 1,768 institutional managers reporting a position
Largest by reported value
  1. Capital World Investors $13B
  2. Black Rock, Inc. $12B
  3. Capital Research Global Investors $9.68B
5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Vertex Pharmaceuticals Inc MA
All Vertex Pharmaceuticals Inc MA insider activity
GET /v1/forms/4/0000875320-26-000272 API docs
View Original SEC Filing